Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NSE/LAXMIDENTL stock hub

NSE/LAXMIDENTL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/LAXMIDENTLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
11.8B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/LAXMIDENTL
In the news

Latest news · NSE/LAXMIDENTL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.3
P25 24.9P50 32.4P75 45.7
Trailing P/E48.8
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC9.4
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/LAXMIDENTL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
150
Groups with data
10
Currency
INR
Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
2,390
Enterprise value
INR 11.7B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
INE0WO601020
Last refreshed
2026-05-10
Market cap
INR 11.8B
Price
INR 215
Price currency
INR
Rev Per Employee
1,106,987.45x
Sector
Healthcare
Sic
3843
Symbol
nse/LAXMIDENTL
Website
https://www.laxmidentallimited.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
1.96%
EV Earnings
50.33x
EV/EBIT
42.06x
EV/EBITDA
26.85x
EV/Sales
4.41x
Forward P/E
25.31x
P/B ratio
5.15x
P/E ratio
48.78x
P/S ratio
4.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
EBIT Margin
9.06%
EBITDA Margin
13.21%
Gross margin
73.63%
Gross Profit
INR 1.9B
Gross Profit Growth
8.02%
Gross Profit Growth Q
0.79%
Net Income
INR 231.8M
Net Income Growth
-34.61%
Net Income Growth Q
-58.83%
Net Income Growth Years
0%
Pretax Margin
10.42%
Profit Margin
8.76%
Profit Per Employee
INR 96,979
Profitable Years
1
ROIC
9.4
Roic5y
6.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
-44.3%
EPS Growth
-32.18
EPS Growth Q
-59.09
EPS Growth Years
0
Revenue Growth
13.31x
Revenue Growth Q
7.1x
Revenue Growth Quarters
1x
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

12
MetricValue
Cash
INR 246.2M
Debt
INR 89.1M
Debt EBITDA
INR 0.22
Debt Equity
INR 0.04
Equity
INR 2.3B
Interest Coverage
10.61
Net Cash
INR 157.1M
Net Cash By Market Cap
INR 1.33
Net Debt EBITDA
INR -0.45
Net Debt Equity
INR -0.07
Tangible Book Value
INR 2.3B
Tangible Book Value Per Share
INR 42.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
2.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-44.28%
200-day SMA
276.4
50-day SMA
188
50-day SMA vs 200-day SMA
50under200
All Time High
584
All Time High Change
-63.15%
All Time High Date
2025-01-20
All Time Low
155.9
All Time Low Change
38.05%
All Time Low Date
2026-03-30
ATR
9.92
Beta1y
0.77
Beta2y
0.8
Ch YTD
-21.01
High
219.5
High52
510
High52 Date
2025-07-21
High52ch
-57.8%
Low
214.8
Low52
155.9
Low52 Date
2026-03-30
Low52ch
38.06%
Ma50ch
14.48%
Price vs 200-day SMA
-22.14%
RSI
62.33
RSI Monthly
29.92
RSI Weekly
44.21
Sharpe ratio
-1.01x
Sortino ratio
-1.49
Total Return
2.37%
Tr YTD
-21.01
Tr1m
16.46%
Tr1w
2.5%
Tr3m
5.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
INR 239.6M
Operating Income Growth
-23.1
Operating Income Growth Q
-50.63
Operating margin
9.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
16,374,906%
Shares Insiders
47.8%
Shares Institutions
25.08%
Shares Out
54,962,149
Shares Qo Q
1.63%
Shares Yo Y
-2.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

42
MetricValue
Average Volume
223,874.25x
Bv Per Share
42.72
Ch1m
16.46
Ch1w
2.5
Ch1y
-44.28
Ch3m
5.86
Ch6m
-30.98
Change
-1.14%
Change From Open
-1.06
Close
217.7
Days Gap
-0.08
Depreciation Amortization
109,765,000
Dollar Volume
18,337,837.6
Earnings Date
2026-05-26
EBIT
INR 239.6M
EBITDA
INR 349.4M
EPS
INR 4.41
F Score
1
Fiscal Year End
March
Founded
2,004
Graham Number
65.10396
Graham Upside
-69.75
Income Tax
INR 44.7M
Is Primary Listing
1
Last Earnings Date
2026-02-10
Last Report Date
2025-12-31
Ma150
242.4
Ma150ch
-11.23%
Ma20
200.1
Ma20ch
7.56%
Next Earnings Date
2026-05-26
Open
217.5
Position In Range
9.47
Price Date
2026-05-08
Price EBITDA
INR 33.84
Ptbv Ratio
5.2
Relative Volume
0.38x
Revenue
2,645,700,000x
Tax By Revenue
1.69x
Tax Rate
16.23%
Tr6m
-30.98%
Volume
85,213
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NSE/LAXMIDENTL pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/LAXMIDENTL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-44.3%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NSE/LAXMIDENTL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+25.1%
Share of float held by funds and institutions
Insider ownership
+47.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.4%
Negative means the company is buying back shares.
Technical

NSE/LAXMIDENTL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
62.3
Neutral momentum band
Price vs 200-day MA
-22.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-1.01
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/LAXMIDENTL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/LAXMIDENTL stock rating?

nse/LAXMIDENTL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/LAXMIDENTL analysis?

The full report lives at /stocks/nse/LAXMIDENTL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/LAXMIDENTL?

The latest report frames nse/LAXMIDENTL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/LAXMIDENTL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.